We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

Share Price Information for ADVFN (AFN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 1.00 (10.00%)
Open: 10.50
High: 10.50
Low: 10.50
Prev. Close: 10.50
AFN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

21 Mar 2024 09:49

RNS Number : 7911H
ADVFN PLC
21 March 2024

21 March 2024

For immediate release

ADVFN PLC

("ADVFN" or the "Group")

Unaudited Interim Results for the Six Months Ended 31 December 2023

ADVFN today announces its unaudited interim results for the six months ended 31 December 2023 (the "Period").

Chief Executive's Statement

As we release our interim report, the Board reaffirms its commitment to implementing its long-term plans to improve financial results.

The first stages of this are in place. I wish to highlight our recent partnership with Prodesfin S.R.L, who own and operate the financial website Financiallounge.com in Italy and also the changes and redesign of our product offering some of which are evident on our www.advfn.com site. We're on track to conclude these enhancements by the end of Q2 2024.

We have continued to reduce costs and the cash burn rate and we've maintained a healthy cash balance of £4.7 million at the Period end , aligning with the financial objectives outlined in previous reports. This has led to reduced losses over the comparable period to last year of (£531k; 2023 £622k) despite a decrease in revenues. The decrease in revenues was primarily attributable to continued adverse market conditions and the discontinuance of company units which no longer supported our business goals.

We remain focused on continuing this improved trend in the upcoming H1 and H2 of 2024.

Amit Tauman

CEO

21 March 2024

Condensed interim consolidated income statement

6 months to

31 Dec

6 months to

31 Dec

12 months to

30 June

2023

2022

2023

£'000

£'000

£'000

unaudited

unaudited

audited

Notes

Revenue

2,294

3,061

5,445

Cost of sales

(109)

(196)

(316)

Gross profit

2,185

2,865

5,129

Share based payment

(9)

-

319

Amortisation of intangible assets

(84)

(91)

(191)

Administrative expenses

(2,703)

(3,390)

(6,026)

Administrative expenses - non-recurring items

-

-

(1,178)

Total administrative expense

(2,796)

(3,481)

(7,076)

Operating loss

(611)

(616)

(1,947)

Finance income

80

24

Finance expense

(1)

(6)

(11)

Other income

-

-

20

Loss before tax

(532)

(622)

(1,914)

Taxation

1

-

58

Loss from continuing operations

(531)

(622)

(1,856)

Loss from discontinued operations

-

-

(313)

Total loss for the period attributable to shareholders of the parent

(531)

(622)

(2,169)

Loss per share from continuing operations

RESTATED

Basic

-

-

(5.16p)

Diluted

-

-

(5.16p)

Loss per share from total operations

Basic

3

(1.16p)

(2.35p)

(6.03p)

Diluted

(1.16p)

(2.35p)

(6.03p)

Condensed interim consolidated statement of comprehensive income

6 months to

31 Dec

6 months to

31 Dec

12 months to

30 June

2023

2022

2023

£'000

£'000

£'000

unaudited

unaudited

audited

Loss for the period

(531)

(622)

(2,169)

Other comprehensive income:

Items that will be reclassified subsequently to profit or loss:

Exchange differences on translation of foreign operations

28

41

33

Total other comprehensive income

28

41

33

Total comprehensive loss for the period attributable to shareholders of the parent

(503)

(581)

(2,136)

Condensed interim consolidated balance sheet

31 Dec

31 Dec

30 June

2023

2022

2023

£'000

£'000

£'000

unaudited

unaudited

audited

Assets

Non-current assets

Property, plant and equipment (including right of use assets)

145

51

160

Goodwill and intangible assets

959

2,054

1,003

Other receivables

22

26

25

1,126

2,131

1,188

Current assets

Trade and other receivables

460

368

466

Cash and cash equivalents

4,798

647

5,557

5,258

1,015

6,023

Total assets

6,385

3,146

7,211

Equity and liabilities

Equity

Issued capital

92

53

92

Share premium

6,676

305

6,676

Share based payments reserve

32

341

22

Foreign exchange translation reserve

344

324

316

Retained earnings

(2,360)

(282)

(1,828)

4,783

741

5,278

Non-current liabilities

Borrowing - bank loans

15

34

20

15

34

20

Current liabilities

Trade and other payables

1,576

2,314

1,903

Borrowing - bank loans

10

13

10

Lease liabilities

-

44

-

1,586

2,371

1,913

Total liabilities

1,601

2,405

1,933

Total equity and liabilities

6,384

3,146

7,211

Condensed interim consolidated statement of changes in equity

Share capital

Share premium

Share based payment reserve

Foreign exchange translation reserve

Retained earnings

Total equity

£'000

£'000

£'000

£'000

£'000

£'000

At 1 July 2022

53

305

341

283

340

1,322

Loss for the period after tax

-

-

-

-

(622)

(622)

Other comprehensive income

Exchange differences on translation of foreign operations

-

-

-

41

-

41

Total comprehensive (loss)/income

-

-

-

41

(622)

(581)

At 31 December 2022

53

305

341

324

(282)

741

Transactions with equity shareholders:

Shares issued

39

6,448

-

-

-

6,487

Cost associated with the issue of shares

-

(77)

-

-

-

(77)

Issue of options

-

-

1

-

-

1

Lapsed options

-

-

(320)

-

-

(320)

39

6,371

(319)

-

-

6,091

Loss for the period after tax

-

-

-

-

(1,546)

(1,546)

Other comprehensive income

Exchange differences on translation of foreign operations

-

-

-

(8)

-

(8)

Total other comprehensive income

-

-

-

(8)

-

(8)

Total comprehensive loss

-

-

-

(8)

(1,546)

(1,554)

At 30 June 2023

92

6,676

22

316

(1,828)

5,278

Transactions with equity shareholders:

Issue of options

-

-

10

-

-

10

92

6,676

32

316

(1,828)

5,288

Loss for the period after tax

-

-

-

-

(531)

(531)

Other comprehensive income

Exchange differences on translation of foreign operations

-

-

-

28

-

28

Total comprehensive (loss)/income

-

-

-

28

(531)

(503)

At 31 December 2023

92

6,676

32

344

2,359

4,785

Condensed interim consolidated cash flow statement

6 months to

31 Dec

6 months to

31 Dec

12 months to

30 June

2023

2022

2023

£'000

£'000

£'000

unaudited

unaudited

audited

Cash flows from continuing operating activities

Loss for the period from continuing operations

(531)

(622)

(1,855)

Net finance (income)/expense in the income statement

(79)

6

(13)

Depreciation of property, plant and equipment

16

53

75

Amortisation of intangible assets

84

91

191

Write off goodwill

-

-

978

Share based payments

10

(319)

Decrease / (Increase) in trade and other receivables

(16)

92

(20)

Increase / (decrease) in trade and other payables

(328)

167

(226)

Net cash used by continuing operations

(844)

(213)

(1,189)

Cashflow from discontinued operating activities

Loss for the year from discontinued operations

-

-

(313)

Amortisation of intangible assets

-

-

23

Write off intangible assets

-

-

83

Decrease in trade and other receivables

-

-

14

Decrease in trade and other payables

-

-

(23)

Net cash used by discontinued operations

-

-

(216)

Income tax receivable

25

-

-

Net cash used by operating activities

(819)

(213)

(1,405)

Cash flows from financing activities

Issue of share capital

-

-

6,410

Dividend payments

-

-

(589)

Bank interest received

80

-

24

Repayment of loans

(5)

(7)

(24)

Repayments of lease liabilities

-

(44)

(91)

Lease interest paid

-

(3)

(4)

Other interest paid

(1)

(3)

(1)

Net cash (used)/generated by financing activities

74

(57)

6,314

Cash flows from investing activities

Payments for property, plant and equipment

(2)

(6)

(136)

Purchase of intangibles

(40)

-

(175)

Net cash used by investing activities

(42)

(6)

(311)

Net (decrease)/increase in cash and cash equivalents

(787)

(276)

4,598

Gain on foreign exchange

28

8

44

Net increase/(decrease) in cash and cash equivalents

(759)

(268)

4,642

Cash and cash equivalents at the start of the period

5,557

915

915

Cash and cash equivalents at the end of the period

4,798

647

5,557

1. Legal status and activities

The principal activity of ADVFN PLC ("the Company") and its subsidiaries (together "the Group") is the development and provision of financial information, primarily via the internet, research services and the development and exploitation of ancillary internet sites.

The principal trading subsidiaries are All IPO Plc (strike off applied for), InvestorsHub.com Inc and N A Data Inc,

The Company is a public limited company which is quoted on the AIM of the London Stock Exchange and is incorporated and domiciled in the UK. The address of the registered office is Suite 28, Essex Business Centre, The Gables, Fyfield Road, Ongar, Essex, CM5 0GA.

The registered number of the company is 02374988.

2. Basis of preparation of the half-year report

These condensed interim financial statements have been prepared in accordance with IAS 34, "Interim Financial Reporting".

The financial information does not include all the information required for full annual financial statements. The same accounting policies and methods of computation have been followed in the interim financial statements as compared with the full audited financial statements and should be read in conjunction with the consolidated financial statements of the Group for the year ended 30 June 2023, which were prepared under applicable law and in accordance with UK-adopted international accounting standards.

The unaudited consolidated interim financial information is for the six-month period ended 31 December 2023. These financial statements were approved for issue on 19th March 2024.

The financial statements are presented in Sterling (£) rounded to the nearest thousand except where specified.

The interim financial information has been prepared on the going concern basis which assumes the Group will continue in existence for the foreseeable future.

No material uncertainties that cast significant doubt about the ability of the Group to continue as a going concern have been identified by the directors. Accordingly, the directors believe it is appropriate for the interim financial statement to be prepared on the going concern basis.

The principal risks and uncertainties of the Company remain the same as those reported in the consolidated financial statements of the Group for the year ended 30 June 2023. The critical estimates and judgements remain the same as those applied to the consolidated financial statements for the Group for the year ended 30 June 2023.

The interim financial information has not been audited nor has it been reviewed under ISRE 2410 of the Auditing Practices Board. The financial information presented does not constitute statutory accounts as defined by section 434 of the Companies Act 2006. The Group's statutory accounts for the year to 30 June 2023 have been filed with the Registrar of Companies. The auditors, Saffery Champness LLP reported on these accounts and their report was unqualified and did not contain a statement under section 498(2) or Section 498(3) of the Companies Act 2006.

3. Loss per share

6 months to

6 months to

12 months to

31 Dec 2023

31 Dec 2022

30 June 2023

£'000

£'000

£'000

Loss for the year attributable to equity shareholders from continuing operations

(531)

(622)

(1,856)

Loss for the year attributable to equity shareholders from total operations

(531)

(622)

(2,169)

Shares

Shares

Weighted average number of shares

Number of shares in issue prior to rights issue (prior year: weighted average)

46,004,758

26,315,318

26,315,318

Correction for deemed rights issue

-

169,179

169,179

Deemed number of shares before rights issue

46,004,758

26,484,497

26,484,497

Weighted average shares

26,484,497 x 188/365 (prior to rights issue)

-

-

13,641,330

46,004,758 x 177/365 (post rights issue)

-

-

22,309,157

Total weighted average number of shares

46,004,758

26,484,497

35,950,487

Loss per share for the year attributable to equity shareholders from continuing operations:

Basic and diluted

-

-

(5.16p)

Total loss per share for the year attributable to equity shareholders:

Basic and diluted

(1.16p)

(2.35p)

(6.03p)

Basic and diluted loss per share as previously stated

-

(2.36p)

-

Where a loss has been recorded for the year the diluted loss per share does not differ from the basic loss per share.

Where a profit has been recorded but the average share price for the year remains under the exercise price the existence of options is not normally dilutive. However, whilst the average exercise price of all outstanding options is above the average share price there are a number of options which are not. Under these circumstances those options where the exercise price is below the average share price are treated as dilutive.

During the year to 30 June 2023, the company made a rights issue. The prior year earnings to 31 December 2022 have been restated to allow for the effects of this rights issue.

4. Dividends

The directors are not recommending payment of an interim dividend in the current financial year.

5. Events after the balance sheet date

An application for strike off has been submitted for All IPO Plc, in line with the strategic plans for the business.

In February 2024 a partnership agreement was signed with Prodesfin S.r.l in relation to the creation and maintenance of an ADVFN Italian website.

The company is in the process of issuing proceedings against a former director in order to seek damages for various breaches of fiduciary duty. The Company is also in the process of issuing proceedings against Online Blockchain PLC for monies transferred to that company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IR KFLBLZXLZBBD
Date   Source Headline
21st Mar 20249:49 amRNSHalf-year Report
9th Feb 202411:19 amRNSNew ADVFN Italia website is launched
12th Jan 20242:00 pmRNSResult of Meeting
28th Dec 20231:10 pmRNSResult of AGM
21st Dec 20237:00 amRNSFinal Results
5th Dec 20234:00 pmRNSNotice of AGM
16th Nov 20231:30 pmRNSHolding(s) in Company
21st Sep 202312:00 pmRNSADFVN connects audience to Doceo content
15th Aug 20236:05 pmRNSCorporate update
9th Jun 20236:15 pmRNSDirector/PDMR Shareholding
2nd Jun 202312:14 pmRNSTrading and corporate update
16th May 20234:33 pmRNSHolding(s) in Company
5th May 20233:06 pmRNSTotal Voting Rights
4th Apr 20237:00 amRNSIssue of Equity
30th Mar 20232:07 pmRNSHolding(s) in Company
30th Mar 20232:05 pmRNSHolding(s) in Company
23rd Mar 20235:02 pmRNSHolding(s) in Company
23rd Mar 20235:01 pmRNSHolding(s) in Company
23rd Mar 20235:00 pmRNSHolding(s) in Company
23rd Mar 20233:30 pmRNSDirector/PDMR Shareholding
20th Mar 20236:20 pmRNSAdmission update
14th Mar 202312:05 pmRNSFurther equity issue under the Open Offer
6th Mar 20237:00 amRNSHalf-year Report
6th Feb 202311:53 amRNSDirectorate Change
13th Jan 202311:19 amRNSResult of AGM
11th Jan 20231:15 pmRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
10th Jan 20237:00 amRNSCorporate update
9th Jan 20235:22 pmRNSTotal voting rights, Director / PDMR shareholding
6th Jan 20232:04 pmRNSFinal Results of Open Offer
6th Jan 20237:00 amRNSResults of Open Offer
20th Dec 20227:00 amRNSOpen Offer timetable and AGM
6th Dec 20227:00 amRNSOpen Offer
6th Dec 20227:00 amRNSFinal Results
28th Nov 20227:00 amRNSCorporate update
15th Sep 202210:45 amRNSAppointment of joint corporate broker
19th Aug 20224:15 pmRNSCorporate update
8th Aug 20227:00 amRNSDirectorate Change
6th Jun 20227:00 amRNSTrading and Corporate Update
29th Apr 20222:05 pmRNSResult of Meeting
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20222:01 pmRNSHolding(s) in Company
22nd Apr 20224:00 pmRNSTotal Voting Rights
20th Apr 202211:05 amRNSSecond Price Monitoring Extn
20th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20229:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.